Sirén AL - Search Results

1

Reduced oxidative damage in ALS by high-dose enteral melatonin treatment.

Weishaupt JH, Bartels C, Pölking E, Dietrich J, Rohde G, Poeggeler B, Mertens N, Sperling S, Bohn M, Hüther G, Schneider A, Bach A, Sirén AL, Hardeland R, Bähr M, Nave KA, Ehrenreich H. Weishaupt JH, et al. Among authors: siren al. J Pineal Res. 2006 Nov;41(4):313-23. doi: 10.1111/j.1600-079X.2006.00377.x. J Pineal Res. 2006. PMID: 17014688 Clinical Trial.

2

Melatonin as a candidate compound for neuroprotection in amyotrophic lateral sclerosis (ALS): high tolerability of daily oral melatonin administration in ALS patients.

Jacob S, Poeggeler B, Weishaupt JH, Sirén AL, Hardeland R, Bähr M, Ehrenreich H. Jacob S, et al. Among authors: siren al. J Pineal Res. 2002 Oct;33(3):186-7. doi: 10.1034/j.1600-079x.2002.02943.x. J Pineal Res. 2002. PMID: 12220335 No abstract available.

3

Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells.

Weishaupt JH, Rohde G, Pölking E, Siren AL, Ehrenreich H, Bähr M. Weishaupt JH, et al. Among authors: siren al. Invest Ophthalmol Vis Sci. 2004 May;45(5):1514-22. doi: 10.1167/iovs.03-1039. Invest Ophthalmol Vis Sci. 2004. PMID: 15111610

4

Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis.

Ehrenreich H, Fischer B, Norra C, Schellenberger F, Stender N, Stiefel M, Sirén AL, Paulus W, Nave KA, Gold R, Bartels C. Ehrenreich H, et al. Among authors: siren al. Brain. 2007 Oct;130(Pt 10):2577-88. doi: 10.1093/brain/awm203. Epub 2007 Aug 29. Brain. 2007. PMID: 17728357 Clinical Trial.

5

Soccer, neurotrauma and amyotrophic lateral sclerosis: is there a connection?

Piazza O, Sirén AL, Ehrenreich H. Piazza O, et al. Among authors: siren al. Curr Med Res Opin. 2004 Apr;20(4):505-8. doi: 10.1185/030079904125003296. Curr Med Res Opin. 2004. PMID: 15119987 Review.

6

A hematopoietic growth factor, thrombopoietin, has a proapoptotic role in the brain.

Ehrenreich H, Hasselblatt M, Knerlich F, von Ahsen N, Jacob S, Sperling S, Woldt H, Vehmeyer K, Nave KA, Sirén AL. Ehrenreich H, et al. Among authors: siren al. Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):862-7. doi: 10.1073/pnas.0406008102. Epub 2005 Jan 10. Proc Natl Acad Sci U S A. 2005. PMID: 15642952 Free PMC article.

7

Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system.

Sirén AL, Fasshauer T, Bartels C, Ehrenreich H. Sirén AL, et al. Neurotherapeutics. 2009 Jan;6(1):108-27. doi: 10.1016/j.nurt.2008.10.041. Neurotherapeutics. 2009. PMID: 19110203 Free PMC article. Review.

8

Endothelin B receptor deficiency augments neuronal damage upon exposure to hypoxia-ischemia in vivo.

Sirén AL, Lewczuk P, Hasselblatt M, Dembowski C, Schilling L, Ehrenreich H. Sirén AL, et al. Brain Res. 2002 Jul 26;945(1):144-9. doi: 10.1016/s0006-8993(02)02911-6. Brain Res. 2002. PMID: 12113963

9

A novel role for an established player: anemia drug erythropoietin for the treatment of cerebral hypoxia/ischemia.

Ehrenreich H, Timner W, Sirén AL. Ehrenreich H, et al. Among authors: siren al. Transfus Apher Sci. 2004 Aug;31(1):39-44. doi: 10.1016/j.transci.2004.05.001. Transfus Apher Sci. 2004. PMID: 15294194 Review.

10

Expression patterns of erythropoietin and its receptor in the developing spinal cord and dorsal root ganglia.

Knabe W, Sirén AL, Ehrenreich H, Kuhn HJ. Knabe W, et al. Among authors: siren al. Anat Embryol (Berl). 2005 Oct;210(3):209-19. doi: 10.1007/s00429-005-0019-3. Epub 2005 Oct 18. Anat Embryol (Berl). 2005. PMID: 16151855

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

154 results

Search Page